p16 Expression in Squamous and Trophoblastic Lesions of the Upper Female Genital Tract

被引:25
作者
Chew, Ivy [1 ]
Post, Miriam D. [3 ]
Carinelli, Silvestro G. [5 ]
Campbell, Sharon [1 ]
Di, Ye [2 ]
Soslow, Robert A. [4 ]
Oliva, Esther [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Univ Colorado, Dept Pathol, Denver, CO 80202 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[5] Fdn Osped Policlin, Dept Pathol, Milan, Italy
关键词
p16; Squamous cell carcinoma; Endometrioid adenocarcinoma with squamous differentiation; Placental site nodule; Placental site trophoblastic tumor; CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN PAPILLOMAVIRUS DETECTION; BENIGN CYSTIC TERATOMA; CELL-CYCLE CONTROL; CANCER STUDY-GROUP; ENDOCERVICAL ADENOCARCINOMAS; ENDOMETRIAL CARCINOMAS; DIFFERENTIAL-DIAGNOSIS; OVARIAN-CARCINOMA; PRB EXPRESSION;
D O I
10.1097/PGP.0b013e3181e2fe70
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
p16, a surrogate marker for human papillomavirus (HPV) infection, is uniformly present in HPV-related carcinomas. This study aims to further characterize p16 expression in trophoblastic lesions and squamous lesions of the upper female genital tract, as little data exists. p16 immunostaining was performed on sections from ichthyosis uteri (1), primary uterine corpus squamous cell carcinoma (UCSCC) (2), primary ovarian SCC (OSCC) (5; 2 associated with a dermoid cyst), endometrial endometrioid adenocarcinoma with extensive squamous differentiation (EC-SD) (5), ovarian endometrioid adenocarcinoma with extensive squamous differentiation (OC-SD) (4), placental site nodule (5), and placental site trophoblastic tumor (PSTT) (6). We evaluated the percentage of positive cytoplasmic and nuclear staining (focal = <10%, multifocal = 10% to 50%, and diffuse = >50%) and staining intensity (weak, moderate, and strong). HPV-DNA analysis by polymerase chain reaction was performed on 5 OSCC. Ichthyosis uteri, all UCSCC and 1 OSCC (arising in a dermoid) were negative; the other dermoid-associated OSCC showed focal moderate staining, the remaining OSCC displayed strong (100%), diffuse (2), or multifocal (1) p16 positivity. Three of the 5 EC-SD cases showed strong diffuse staining of the squamous component. The glandular component focally showed strong p16 positivity (2), with variably intense focal staining in 3 cases. The squamous component of all OC-SD showed focal moderate staining, with variable staining of the glandular component. Overall, 3 EC-SD had 80% to 90% p16 positivity. Five of the 5 placental site nodules and 4 of the 6 PSTT showed focal weak staining, whereas 2 PSTT were p16 negative. HPV-DNA analysis was negative in 3 of the 5 OSCC, the other 2 cases being technical failures. p16 is expressed in OSCC and in the squamous and glandular components of EC-SD and OC-SD. As p16 is negative in UCSCC, it may help to identify the origin of SCC diffusely involving the corpus and cervix, and suggests different pathogeneses for SCC of the upper female genital tract, likely to be unrelated to HPV infection. In contrast to earlier data, we found weak and focal p16 expression in trophoblastic lesions. Thus, when considering the differential diagnosis of cervical SCC and trophoblastic lesions, only strong diffuse p16 staining should be considered helpful.
引用
收藏
页码:513 / 522
页数:10
相关论文
共 84 条
[1]   SQUAMOUS-CELL NEOPLASMS ARISING FROM OVARIAN BENIGN CYSTIC TERATOMA [J].
AMERIGO, J ;
NOGALES, FF ;
FERNANDEZSANZ, J ;
OLIVA, H ;
VELASCO, A .
GYNECOLOGIC ONCOLOGY, 1979, 8 (03) :277-283
[2]   Distinction of endocervical and endometrial adenocarcinomas - Immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection [J].
Ansari-Lari, MA ;
Staebler, A ;
Zaino, RJ ;
Shah, KV ;
Ronnett, BM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (02) :160-167
[3]   Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein [J].
Armes, Jane E. ;
Lourie, Rohan ;
de Silva, Melanie ;
Stamaratis, Georgia ;
Boyd, Alison ;
Kumar, Beena ;
Price, Gareth ;
Hyde, Simon ;
Allen, David ;
Grant, Peter ;
Venter, Deon J. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (04) :363-368
[4]  
Baggish M S, 1967, Obstet Gynecol Surv, V22, P69
[5]   Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas [J].
Bai, M ;
Vlachonikolis, J ;
Agnantis, NJ ;
Tsanou, E ;
Dimou, S ;
Nicolaides, C ;
Stefanaki, S ;
Pavlidis, N ;
Kanavarous, P .
MODERN PATHOLOGY, 2001, 14 (11) :1105-1113
[6]   The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung [J].
Beasley, MB ;
Lantuejoul, S ;
Abbondanzo, S ;
Chu, WS ;
Hasleton, P ;
Travis, WD ;
Brambilla, E .
HUMAN PATHOLOGY, 2003, 34 (02) :136-142
[7]  
BERGERON C, 1988, OBSTET GYNECOL, V72, P383
[8]  
Bewtra Chhanda, 2005, Arch Pathol Lab Med, V129, pe124
[9]  
BLACK WC, 1964, OBSTET GYNECOL, V24, P865
[10]   Comparative Analysis of P16 and P53 Expression in Uterine Malignant Mixed Mullerian Tumors [J].
Buza, Natalia ;
Tavassoli, Fattaneh A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2009, 28 (06) :514-521